Tianjin TEDA Biomedical Engineering Co. Ltd.

  • Market Cap: N/A
  • Industry: Chemicals & Petrochemicals
  • ISIN: CNE1000004H7
HKD
0.29
-0.12 (-28.4%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Sinofert Holdings Ltd.
Cheerwin Group Ltd.
China BlueChemical Ltd.
China XLX Fertiliser Ltd.
Tianjin TEDA Biomedical Engineering Co. Ltd.
Ko Yo Chemical (Group) Ltd.
Century Sunshine Group Holdings Ltd.
Dongguang Chemical Ltd.

Why is Tianjin TEDA Biomedical Engineering Co. Ltd. ?

1
Poor long term growth as Net Sales has grown by an annual rate of -6.24% and Operating profit at -8.63% over the last 5 years
2
The company declared negative results in Dec'24 after positive results in Jun'24
  • OPERATING CASH FLOW(Y) Lowest at HKD -150.24 MM
  • PRE-TAX PROFIT(Q) Fallen at -51.24%
  • NET PROFIT(Q) Fallen at -54.5%
3
With ROE of 26.18%, it has a Very Expensive valuation with a 26.86 Price to Book Value
  • Over the past year, while the stock has generated a return of -37.63%, its profits have fallen by -77.7%
4
Underperformed the market in the last 1 year
  • Even though the market (Hang Seng Hong Kong) has generated returns of 8.25% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -37.63% returns
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals & Petrochemicals)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Tianjin TEDA Biomedical Engineering Co. Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Tianjin TEDA Biomedical Engineering Co. Ltd.
-100.0%
5.34
52.75%
Hang Seng Hong Kong
8.25%
0.41
19.93%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-6.24%
EBIT Growth (5y)
-8.63%
EBIT to Interest (avg)
5.03
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
3.87
Sales to Capital Employed (avg)
2.73
Tax Ratio
32.95%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3,418.30%
ROE (avg)
1,933.92%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
103
Industry P/E
Price to Book Value
26.86
EV to EBIT
37.66
EV to EBITDA
24.70
EV to Capital Employed
6.31
EV to Sales
1.59
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
16.76%
ROE (Latest)
26.18%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
NET PROFIT(HY)

Higher at HKD -6.9 MM

RAW MATERIAL COST(Y)

Fallen by -90.3% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at 62.42 %

INVENTORY TURNOVER RATIO(HY)

Highest at 4.58 times

NET SALES(Q)

Highest at HKD 243.2 MM

-5What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at HKD -150.24 MM

PRE-TAX PROFIT(Q)

Fallen at -51.24%

NET PROFIT(Q)

Fallen at -54.5%

Here's what is working for Tianjin TEDA Biomedical Engineering Co. Ltd.

Net Sales
Highest at HKD 243.2 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (HKD MM)

Debt-Equity Ratio
Lowest at 62.42 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Inventory Turnover Ratio
Highest at 4.58 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost
Fallen by -90.3% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Tianjin TEDA Biomedical Engineering Co. Ltd.

Operating Cash Flow
Lowest at HKD -150.24 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (HKD MM)

Pre-Tax Profit
Fallen at -51.24%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (HKD MM)

Net Profit
Fallen at -54.5%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is negative

Net Profit (HKD MM)